注意: 獲獎人名字使用藍色標記

Award in 2017

 

1.      Liang C, Peng S, Zhang BT, Lu Aiping, Zhang G. From precision medicine to drug discovery: inhibition of osteoblastic Smurf1 promotes bone formation in distinctive individuals with age-related osteoporosis. Webster Jee Young Investigator Award. 2017   ICMRS-ORS Membership Meeting, March 20, 2017. San Diego, California, USA.

 

2.      Yu Y, Li Y, Wu X, Li F, Lu A, Zhang G. An innovative gain-loss cell-SELEX strategy for the development of a nucleic acid aptamer against PD-L1 for immunotherapy of triple negative breast cancer. Poster Abstract. Travel Award. Aptamer 2017, 11-12 April 2017.   St. Hilda’s College, Oxford, UK

 

3.      Dang L, Shaikh AB. Osteoblastic Plekho1 contributes to articular inflammation and bone repair failure in rheumatoid arthritis. The third prize. The National Competition – Hong Kong Regional Final – Hong Kong University Student Innovation and Entrepreneurship Competition 2017, May 22-23 2017. Hong Kong, China

 

4.      Lu J, Li FF, Liu J. Develop a Highly Water Soluble Nucleolin Aptamer Paclitaxel Conjugate with a Cathepsin Labile Linker for Tumor-Specific Targeting in Ovarian Cancer. The second prize. "Entrepreneurship Challenge Cup"- the National Competition - Hong Kong Regional Final, May 22-23, 2017, Hong Kong, China

 

5.      Dang L. Research scholarship provided by the “Wai Tak Land Investment & Loan Co., Ltd.”, 2017

 

Award in 2016

 

1.      Liang C, Lu Aiping, Zhang G.Oligopeptide aptamer-modified chalcone derivative specifically targets Smurf1 in osteoblasts and promotes bone formation. Oral Abstract. Travel Award. Aptamers 2016, 04-05 April 2016. Hilda’s College, Oxford, UK

 

2.      Liu J, Li D, Dang L, Lu A, Zhang G. miR-214-3p targets TRAF3 to promote osteoclastic bone resorption during the development of postmenopausal osteoporosis. ESCEO-AgNovos   Healthcare   Young Investigator Awards, World Congress on Osteoporosis,   Osteoarthritis and Musculoskeletal Diseases, April 14 -17, 2016, Malaga, Spain.

 

3.      Dang L, Liu J, Li   D.F. A   Delivery System Specifically Approaching Bone Resorption Surfaces to   Facilitate Therapeutic Modulation of microRNAs in Osteoclasts. 1st Runner Up. "Entrepreneurship Challenge Cup" - China Competition - Hong Kong stage,   20-22 June, 2016, Hong Kong, China

 

4.      Wang L.Y., Liang C, Li F.F., Zhang G, Lu A.P. Tumor cell-targeted delivery of CRISPR/Cas9 by aptamer-functionalized lipopolymer for therapeutic genome editing of VEGF-A in osteosarcoma. Oral Abstract. Webster Jee Travel Award, the 8th International   Conference on Osteoporosis and Bone Research, 19-22 October, 2016, Chong Qing, China.

 

5.      Wu X.H., Liu J, Xiao L.B., Lu A.P., Zhang G. Alterations of gut microbiome in rheumatoid arthritis. Oral Abstract. Webster Jee Travel Award, the 8th International       Conference on Osteoporosis and Bone Research, 19-22 October 2016, Chong Qing, China.

a)      .

6.      Liang C, Peng S, Zhang BT,Lu Aiping, Zhang G. Inhibition of osteoblastic Smurf1 promotes bone formation in distinctive individuals with age-related osteoporosis. Oral   Abstract. Best Paper Award. 8th International Conference on Osteoporosis and   Bone Research, October 19-22, 2016, Chongqing, China.

 

Award in 2015

 

1.      Liang C. One-year studentship provided by the “Mr. Kwok Yat Wai and Madam Kwok Chung Bo Fun Graduate School Development Fund”, 2015.

 

2.      Liang C, Guo B, Wu H, Zhang L, Lu A, Zhang G. Aptamer-functionalized delivery system for osteogenic   siRNAs   to achieve osteoblast-specific RNA interference for bone anabolic therapy. 2015 Orthopaedic Research Society (ORS) annual meeting, Las Vegas,     March 28-31, 2015. Certificate.

 

3.      Liu J, Dang L, Li D, Guo B, Lu A,   Zhang G. A delivery system specifically approaching bone   resorption   surfaces to facilitate therapeutic modulation of miRNAs in     osteoclasts. Poster Abstract, Young Investigator Award, ICMRS Conference and     Xiangya Osteoporosis Forum, Changsha, China, Apr 9-11, 2015. Certificate

 

4.      Liang C, Xu M, Xu J, Zhang B, Lu A, Zhang G. Discovery of   Small Molecules to   Promote BMP Signaling and Bone Formation. 6th   Sino-American Symposium on   Clinical and Translational Medicine (SAS-CTM). Abstract. Clinical and   Translational Medicine   Excellent Thesis Awards.

 

5.      Liang C, ASBMR Young Investigator Award for the   European Calcified   Tissue Society (ECTS) Ph.D. Training Course.   University of Siena, Tuscany, Italy. September 13-16, 2015.

 

6.      Li D.F., Liu J, Guo B.S., Dang L, Liang C, Liu B, He B, He   X.J.,   Liang Z.C., Lu A.P., Zhang G. Osteoclast-derived exosomal miR-214 inhibits  osteoblastic bone formation. ASBMR 2015 Annual   Meeting. Oral Presentation.   Abstract. Young Investigator Award.   October 9-12, 2015.

 

7.      Liu J, Li D.F., Guo   B.S., Dang L, Lu A.P., Zhang G. Osteoclastic   miR-214 targets PTEN to   increase bone resorption. ASBMR 2015 Annual Meeting.   Plenary Poster.   Abstract. Young Investigator Travel Grant. October 9-12, 2015.

 

Award in 2014

 

1.      Zhang Ge. Investigation  of molecular function, regulatory mechanism and disease correlation of  ubiquitin ligases. Beijing Science and Technology Awards (First class).2014. Certificate.

 

2.      Zhang Ge. Modernization of traditional anti-osteoporosis Chinese medicine. National Science & Technology Progress Award (Second class).2014. Certificate.

 

3.      Liang C, Guo B, Wu H, Zhang L, Lu A, Zhang G. Aptamer-Functionalized Lipid Nanoparticles (LNPs) Targeting Osteoblasts as a Novel RNA Interference-Based Bone Anabolic Strategy. ASBMR 2014 Annual Meeting. Oral Presentation Abstract. Young Investigator Award. September 12-15, 2014.

 

4.      Liang C, Guo B, Wu H, Zhang L, Lu A, Zhang G. Aptamer-Functionalized Lipid Nanoparticles (LNPs) Targeting Osteoblasts as a Novel RNAi-Based Bone Anabolic Strategy. 5th Sino-American Symposium on Clinical and Translational Medicine (SAS-CTM). Abstract. Clinical and Translational Medicine Excellent Thesis Awards.

 

5.      Dang L, Guo B, Li D, Lu A, Zhang G. A Peptide-functionalized delivery system to target osteoclasts. ASBMR 2014.  Poster Presentation Abstract. Young Investigator Travel Grant Award.  September 11-15, 2014.

 

6.      Baosheng Guo, Liu Jin, Dang lei, Liang Chao, Xiaohua Pan, Lingqiang Zhang, Aiping Lu, Baoting Zhang, Ge Zhang. Up-regulated CKIP-1 expression within osteoblasts associates with reduced BMP signaling and  decreased bone formation during aging, The  excellent thesis award. The 5th Sino-American Symosium on Clinical and Translational Medicine, May 31, 2014, Beijing. Certificate.

 

7.      Liang C, Guo B, Wu H, Zhang L, Lu A, Zhang G.  Aptamer-Functionalized Lipid Nanoparticles (LNPs) Targeting Osteoblasts  as a Novel RNAi-Based Bone Anabolic Strategy. Webster Jee Travel Award. the 7th international Conference on Osteoporosis and Bone Research, Oct 16-19, Xiamen, China.

 

Award in 2013

 

1.      Jin Liu, Does age-related increase in CKIP-1 within mesenchymal stem cells associate with age-related impairment in fracture repair. Oral Presentation Award (2nd Prize), Postgraduate Research Symposium on Regenerative Medicine 2013, Guangzhou, China, 2013. Certificate.

 

2.      Biao Liu, Toward targeted therapy in advanced pancreatic cancer: a smart triptolide-nucleolin aptamer conjugate, Oral Presentation Award (3nd Prize), Postgraduate Research Symposium on Regenerative Medicine 2013, Guangzhou, China, 2013.  Certificate

 



版权所有 ©2013 - 2015 岑尧宽岑碧泉纪念癌症炎症研究中心